Advertisement

Bulletin of Experimental Biology and Medicine

, Volume 119, Issue 3, pp 219–224 | Cite as

A soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitrogen oxide and in the regulation of platelet aggregation

  • I. S. Severina
Reviews
  • 19 Downloads

Abstract

The articles is devoted to the role of heme in soluble guanylate cyclase functioning, the molecular mechanism of nitrogen oxide activation of guanylate cyclase, the role of guanylate cyclase in the process of platelet aggregation, and the mechanism of the antihypertensive and antiaggregative action of certain activators of the enzyme.

Key Words

guanylate cyclase heme nitrogen oxide human platelets aggregation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    O. G. Busygina and I. S. Severina,Biokhimiya,55, 1812–1819 (1990).Google Scholar
  2. 2.
    O. G. Busygina and I. S. Severina,,56, 487–492 (1991).Google Scholar
  3. 3.
    L. B. Volodarskii and L. A. Tikhonova,Khimiya Geterotsikl. Soed.,6, 748–752 (1985).Google Scholar
  4. 4.
    I. K. Ryaposova, N. B. Grigor'ev, and I. S. Severina,Biokhimiya,59, 537–542 (1994).Google Scholar
  5. 5.
    I. S. Severina, Yu. Yu. Chirkov, N. N. Belushkina,et al.,,55, 1717–1723 (1990).Google Scholar
  6. 6.
    Yu. Yu. Chirkov, N. N. Belushkina, I. A. Tyshchuk, and I. S. Severina,Vest. Akad. Med. Nauk SSSR,10, 51–54 (1991).Google Scholar
  7. 7.
    Yu. Yu. Chirkov, I. A. Tyshchuk, and I. S. Severina,Vopr. Med. Khim.,4, 57–60 (1990).Google Scholar
  8. 8.
    A. A. Boldyrev, A. M. Dupin, A. Yu. Bunin,et al., Biochem. Int.,15, 1105–1113 (1990).Google Scholar
  9. 9.
    A. A. Boldyrev and S. E. Severin,Adv. Enzym. Regul.,30, 175–190 (1990).CrossRefGoogle Scholar
  10. 10.
    Yu. Yu. Chirkov, I. A. Tyshchuk, and I. S. Severina,Experientia,46, 697–699 (1990).CrossRefGoogle Scholar
  11. 11.
    M. Feelish, and E. A. Noack,Europ. J. Pharmacol.,139, 19–30 (1987).CrossRefGoogle Scholar
  12. 12.
    R. Gerzer, E. Bohme, F. Hoffman, and G. Schultz,FEBS Lett.,14, 71–74 (1991).Google Scholar
  13. 13.
    R. Gerzer, F. Hoffman, and G. Schultz,Europ. J. Biochem.,116, 479–486 (1981).PubMedCrossRefGoogle Scholar
  14. 14.
    R. Gerzer, E. W. Radany, and D. L. Garbers,Biochem. Biophys. Res. Commun.,102, 678–686 (1982).CrossRefGoogle Scholar
  15. 15.
    D. B. Glass, W. Frey, D. W. Carr, and N. D. Goldberg,J. Biol. Chem.,252, 1279–1285 (1977).PubMedGoogle Scholar
  16. 16.
    N. D. Goldberg, M. K. Haddox, S. E. Nicol,et al., Adv. Cycl. Nucl. Res.,5, 307–330 (1975).Google Scholar
  17. 17.
    H. Hidaka and T. Asano,Proc. Nat. Acad. Sci. USA,74, 3657–3661 (1977).PubMedCrossRefGoogle Scholar
  18. 18.
    L. J. Ignarro, J. B. Adams, P. M. Horwitz, and K. S. Wood,J. Biol. Chem.,261, 4997–5002 (1986).PubMedGoogle Scholar
  19. 19.
    L. J. Ignarro and K. S. Wood,Biochim. Biophys. Acta,928, 160–170 (1987).PubMedCrossRefGoogle Scholar
  20. 20.
    L. J. Ignarro, K. S. Wood, and M. S. Wolin,Adv. Cycl. Nucl., Protein Phosphor. Res.,17, 267–274 (1984).Google Scholar
  21. 21.
    L. J. Ignarro, K. S. Wood, and M. S. Wolin,Proc. Nat. Acad. Sci. USA,79, 2870–2873 (1982).PubMedCrossRefGoogle Scholar
  22. 22.
    D. G. Mazhukin, L. B. Volodarsky, L. A. Tichonova, and A. Ya. Tichonov,Mendeleev. Commun.,1, 29–30 (1992).CrossRefGoogle Scholar
  23. 23.
    B. T. Mellion, L. J. Ignarro, E. H. Ohlstein,et al., Blood,57, 946–955 (1981).PubMedGoogle Scholar
  24. 24.
    C. K. Mittal and F. Murad,Proc. Nat. Acad. Sci. USA,74, 4360–4364 (1977).PubMedCrossRefGoogle Scholar
  25. 25.
    K. Nagai and T. Suda,Methods Find. Exp. Clin. Pharmacol.,10, 497–507 (1988).PubMedGoogle Scholar
  26. 26.
    P. M. J. Palmer, D. S. Ashton, and S. Moncada,Nature,333, 664–666 (1988).PubMedCrossRefGoogle Scholar
  27. 27.
    P. M. J. Palmer, A. G. Ferrige, and S. Moncada,,327, 267–274 (1987).CrossRefGoogle Scholar
  28. 28.
    I. S. Severina,Adv. Enzyme Regul.,32, 35–56 (1992).PubMedCrossRefGoogle Scholar
  29. 29.
    I. S. Severina,Biochem. Int.,17, 267–268 (1988).Google Scholar
  30. 30.
    I. S. Severina and N. N. Belushkina,Biochem. Molec. Biol. Int.,33, 957–967 (1994).PubMedGoogle Scholar
  31. 31.
    I. S. Severina, N. N. Belushkina, and N. B. Grigoriev,Biochem. Int.,28, 621–631 (1992).PubMedGoogle Scholar
  32. 32.
    I. S. Severina and O. G. Bussygina,,22, 455–465 (1990).PubMedGoogle Scholar
  33. 33.
    I. S. Severina and O. G. Bussygina,,23, 1143–1154 (1991).PubMedCrossRefGoogle Scholar
  34. 34.
    I. S. Severina, O. G. Bussygina, and N. B. Grigoriev,,26, 695–705 (1992).PubMedGoogle Scholar
  35. 35.
    I. S. Severina, I. K. Ryaposova, I. B. Volodarsky,et al., Biochem. Molec. Biol. Int.,30, 357–366 (1993).PubMedGoogle Scholar
  36. 36.
    J. Tremblay, R. Gerzet, and P. Hamet,Adv. Second Messenger Phosphoprotein Res.,22, 319–385 (1988).PubMedGoogle Scholar
  37. 37.
    S. Tsai, R. A. Admik, V. Manganiello, and M. Vaughan,Biochem. J.,215, 447–455 (1988).Google Scholar

Copyright information

© Plenum Publishing Corporation 1995

Authors and Affiliations

  • I. S. Severina
    • 1
    • 2
  1. 1.Department of Physiologically Active Peptides, Institute of Biomedical ChemistryRussian Academy of Medical Sciences, MoscowMoscowRussia
  2. 2.Guanylate Cyclase System, Institute of Biomedical ChemistryRussian Academy of Medical Sciences, MoscowMoscowRussian

Personalised recommendations